(19)
(11) EP 1 100 495 A1

(12)

(43) Date of publication:
23.05.2001 Bulletin 2001/21

(21) Application number: 99937585.0

(22) Date of filing: 28.07.1999
(51) International Patent Classification (IPC)7A61K 31/34, A61K 31/38, A61K 31/40, A61K 31/42, A61K 31/44, A61K 31/47, A61K 31/135, A61K 31/405, C07C 211/00, C07D 211/06, C07D 491/107
(86) International application number:
PCT/US9917/117
(87) International publication number:
WO 0006/153 (10.02.2000 Gazette 2000/06)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 28.07.1998 US 94405 P

(71) Applicant: SMITHKLINE BEECHAM CORPORATION
PhiladelphiaPennsylvania 19101 (US)

(72) Inventors:
  • BONDINELL, William, E.
    Wayne, PA 19087 (US)
  • NEEB, Michael, J.
    King of Prussia, PA 19406 (US)
  • KU, Thomas, W.
    Dresher, PA 19025 (US)

(74) Representative: Blakey, Alison Jane 
GlaxoSmithKline,Two New Horizons Court
Brentford,Middlesex TW8 9EP
Brentford,Middlesex TW8 9EP (GB)

   


(54) PROPENAMIDES AS CCR5 MODULATORS